Henkel Q3
This article was originally published in The Rose Sheet
Executive Summary
In personal care, "hair, cosmetics and skin care businesses performed particularly well" in the third quarter, contributing to 3% sales growth and an 11.7% jump in operating profit to $52.3 mil., German company reports during Nov. 17 sales and earnings call. Consolidated operating profit grew 7.4% to $204.3 mil., and net earnings rose 11.3% to $140 mil. in the period. Sales grew 3.8% after currency adjustment, but were flat at $2.8 bil. on a constant basis. Third quarter charge of $101 mil. related to restructuring is nearly offset by gain of $96.3 mil. from sale of stake in Wella. Personal care sales are anticipated to grow in the high single digits for the full year following currency adjustments, while overall sales are expected to increase more than 4% after adjusting for currency and acquisitions/divestitures...
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.